US Stock MarketDetailed Quotes

COGT Cogent Biosciences

Watchlist
  • 6.610
  • +0.080+1.23%
Close Apr 18 16:00 ET
  • 6.610
  • 0.0000.00%
Post 17:04 ET
632.00MMarket Cap-2731P/E (TTM)

About Cogent Biosciences Company

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

Company Profile

SymbolCOGT
Company NameCogent Biosciences
Listing DateMar 29, 2018
Issue Price12.00
Founded2014
CEOMr. Andrews R. Robbins, M.B.A.
MarketNASDAQ
Employees164
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address275 Wyman Street,3rd floor
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-617-945-5576
Websitehttp://www.cogentbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Andrews R. Robbins, M.B.A.
  • Director, Chief Executive Officer and President
  • 2.86M
  • John Green
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Jessica Sachs, PhD
  • Chief Medical Officer
  • 3.81M
  • Dr. John Edward Robinson, PhD
  • Chief Scientific Officer
  • 3.47M
  • Evan Kearns
  • Chief Legal Officer and Corporate Secretary
  • --
  • Peter Harwin
  • Chairman of the Board
  • 433.35K
  • Matthew E. Ros
  • Independent Director
  • 403.19K
  • Todd E. Shegog
  • Independent Director
  • 401.67K
  • Dr. Karen Jean Ferrante, M.D.
  • Independent Director
  • 404.85K
  • Arlene M. Morris
  • Independent Director
  • 412.35K
  • Dr. Chris Cain, PhD
  • Independent Director
  • 396.85K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg